Advertisement
Home »

2D4, a humanized monoclonal antibody targeting CD132, is a promising treatment for systemic lupus erythematosus.

Nov 18, 2024

ABOUT THE EXPERTS

  • Huiqi Yin

    Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, China.

    Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.

    Liming Li

    Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, China.

    Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.

    Xiwei Feng

    Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, China.

    Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.

    Zijun Wang

    Department of Dermatology, Second Xiangya Hospital, Central South University, Changsha, China.

    Meiling Zheng

    Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, China.

    Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.

    Junpeng Zhao

    Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, China.

    Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.

    Xinyu Fan

    Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, China.

    Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.

    Wei Wu

    Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, China.

    Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.

    Lingyu Gao

    Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, China.

    Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.

    Yijing Zhan

    Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, China.

    Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.

    Ming Zhao

    Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, China. zhaoming301@pumcderm.cams.cn.

    Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China. zhaoming301@pumcderm.cams.cn.

    Qianjin Lu

    Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, China. qianlu5860@pumcderm.cams.cn.

    Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China. qianlu5860@pumcderm.cams.cn.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


RECOMMENDED ARTICLES FOR YOU

Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

RECOMMENDED ARTICLES FOR YOU

Advertisement